Jointly with our collaborators, we apply these techniques to unique measurement problems in science and engineering. By continuing you agree to the Andrew Moore received his BSc in Engineering Science and PhD in Optical Metrology from Loughborough University in 1988 and 1992 respectively. (Cancer Chemotherapy and Pharmacology, (2017), 80, 1, (15-25), 10.1007/s00280-017-3309-6)Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cellsTelomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapyAssessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry studyStage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registryOutcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 childrenSelective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: A model for emerging clinical resistance patternsIntegrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumorsMolecular minimal residual disease monitoring in acute myeloid leukemia: challenges and future directionsQuizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736A pilot study to investigate the relationship between doxorubicin and doxorubicinol pharmacokinetics and cardiotoxicity in children and adolescents with cancer.Targeting Survivin with YM155 (Sepantronium Bromide): A novel therapeutic strategy for paediatric acute myeloid leukaemiaSecond primary cancers in people who had cancer as children: an Australian Childhood Cancer Registry population-based studyInhibition of Telomerase with Imetelstat Is Detrimental to Leukemia Stem Cells in Acute Myeloid Leukemia (AML)EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemiaThe molecular pathology of infant gliomasVincristine sulfate liposomal injection for acute lymphoblastic leukemia60th Annual Meeting of the American Society of Hematology (ASH)53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Research data for "Measurement of direct strain optic coefficient of YSZ thermal barrier coatings at GHz frequencies" More information on the Optical Diagnostic group can be found at: International Journal of Advanced Manufacturing Technology. Journal Articles Vincristine pharmacodynamics and pharmacogenetics in children with cancer: A limited-sampling, population modelling approach60th Annual Meeting of the American-Society-of-Hematology (ASH)Blood collection technique for pharmacokinetic studies of doxorubicin in paediatric patientsResistance to Selective FLT3 Inhibitors, Driven by FLT3 Ligand and FLT3 Point Mutations, Can Be Overcome with the Dual FLT3-Aurora Kinase Inhibitor CCT241736Novel therapies for children with acute myeloid leukaemiaSpatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine gliomaTargetable kinase-activating lesions in Ph-like acute lymphoblastic leukemiaA stable-isotope HPLC-MS/MS method to simplify storage of human whole blood samples for glutathione assayQuantitative analysis of MLL fusion transcripts by droplet digital PCR to monitor minimal residual disease in MLL-rearranged acute myeloid leukemiaPaediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescentsDifferential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesionsThe outcomes and treatment burden of childhood acute myeloid leukaemia in Australia, 1997-2008: A report from the Australian Paediatric Cancer Registry.The genetic basis and cell of origin of mixed phenotype acute leukaemiaNew brain tumor entities emerge from molecular classification of CNS-PNETsDevelopment of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumoursInfant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes Andrew George Moore (né le 2 juin 1994 à Springfield, Oregon, États-Unis) est un lanceur droitier des Mariners de Seattle de la Ligue majeure de baseball.. Carrière. Re: Hyponatraemia and seizures in oncology patients associated with hypotonic intravenous fluidsThe ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion12th International Congress of Therapeutic Drug Monitoring and Clinical ToxicologyIntegrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma119th Meeting of the British-Neuropathological-Society (BNS) / Epilepsy Neuropathology SymposiumActivation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitorsThe incidence of childhood cancer in Australia, 1983–2015, and projections to 203539th Annual Conference of the International Society of Paediatric Oncology SIOP 2007Vincristine: Can its therapeutic index be enhanced?Localised peripheral primitive neuroectodermal tumour (PNET) of the conjunctiva48th Annual Scientific Meeting of the British Society for HaematologyPTEN deletion drives acute myeloid leukemia resistance to MEK inhibitorsUse of etanercept in children following haematopoietic stem cell transplantation: a single institution experienceBIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupThe Molecular Pathology of Infant GliomasHigh prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatmentAberrant splicing of KMT2A as a potential molecular MRD marker in cytogenetically-normal AMLAdaptation of the plasma inhibitory activity assay to detect Aurora, ABL and FLT3 kinase inhibition by AT9283 in pediatric leukemia